Robert ( dorain)
merck! (producing Iplex )
There is no downside!
Evelyn ( fudfighter#1234)
"I'm currently in discussion with the global Stop TB Partnership, advising them how they should redesign their various therapeutic regimens now that Arikace is available.
When they've finally grasped what they should be doing I'll get in touch with Insmed and give them the benefit of my advice."
Would $165 a share be a fair buyout valuation?
The expectation that the share price will go from the current level to $600 (2013)is entirely realistic. Rating :
(9 Ratings)Rate it: fudfighter
kvncmcdd/alozer if from the Celtrix days look at the chart! chem24 ! You live
They both said 15 or 20 by years end.... what makes both of the resident clowns so valuable is that they both have a perfect record of being wrong for over 8 years.